Currently there are no approved drug delivery method for gene therapy
R&D Focus
DNA-based nanodevices
Innovative Solution
DNA Nanobots uses its IP to create products for targeted chemotherapies, vaccines, point-of-care diagnostics, and functionalized gene delivery
Solution Effectiveness
DNA Nanobots creates targeted therapeutics delivery using its DNA nanoparticle platform
Investment Funding
Startup Stage
Early Stage
People
Founders
Patrick Halley
Christopher Lucas Ph.D
Carlos Castro
Jeffrey Spitzner
CEO
Jeffrey Spitzner
Products
Demo Product or Complete Product?
Development
Awards and Recognitions
Media Apperance
GreyB
M&A and Collabs
Collab
DNA Nanobots Gains Exclusive License to UC Berkeley Gene Editing Technology Platform for Non-Viral Gene Delivery Solution using DNA Nanoparticles and CRISPR-Cas
